Where does aTyr Pharma, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), aTyr Pharma, Inc. ranks #4,320 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does aTyr Pharma, Inc. hold?

aTyr Pharma, Inc. holds 82 US utility patents granted between 2015 and 2025, spanning 10 technology areas.

What is aTyr Pharma, Inc.'s Innovation Score?

aTyr Pharma, Inc. has an Innovation Score of 36.5 out of 100 (top 46% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is aTyr Pharma, Inc.'s patent grant rate increasing or decreasing?

aTyr Pharma, Inc.'s recent grant velocity is -83% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for aTyr Pharma, Inc.'s patents?

aTyr Pharma, Inc.'s patents average 13.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the aTyr Pharma, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

aTyr Pharma, Inc.

Q: What technology areas does aTyr Pharma, Inc. focus on?

aTyr Pharma, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 79 patents. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 82 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, atyr ranks #4,320 of 49,997 tracked US assignees by granted-patent volume, with 82 patents across 10 technology areas.

#4,320
of 49,997 US assignees by volume: Top 46%
by Innovation Score (36.5/100): 13.6
avg claims per patent: -83%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4320 · US Corporation #4,320 · 82 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 82 grants
TOP-DECILE #4,320/49,997
PHOTO-FINISH data world
CPC-FOCUS A61P · 10 areas
INNOV-THIN 36.5/100
CLAIMS-RICH 13.6 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -83% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: data.world, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
aTyr Pharma · this assignee

36
Chevron (HK) · near

36
Schaffert Manufactur… · near

36
Spineology · near

36
Touchstone Internati… · near

36
3D Lighting… · lowest

7

What this shows atyr's Innovation Score is 36.5/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where atyr's grants concentrate

aTyr Pharma, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 96.3% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (21 grants) versus a trough of 1 in 2022. By volume, atyr sits between Ultralogic 6G, LLC and BSH Bosch und Siemens Hausgeräte GmbH.

atyr's three-year grant acceleration

aTyr Pharma, Inc. shows 4 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ultralogic 6G

82
Usnr

82
VAN Cleef & Arpels

82
Yves Saint Laurent

82
data world

82
xmems Labs

82
atyr Pharma ◀

82
Arper S P A

81
BSH Bosch und Sie…

81

What this shows aTyr holds 82 patents at rank #4,364, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near aTyr

By rank, the assignees closest to #4,364 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in aTyr's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for aTyr, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Touchstone International Medical Science Co., Ltd. 36 Spineology Inc. 36 Chevron (HK) Limited 36 Schaffert Manufacturing Company, Inc. 36

Similar claim depth

Nearest assignees by average claims per patent (13.6 here).

Shenzhen TCL NEW Technology Co., Ltd. 13.6 avg DePuy Mitek, LLC 13.6 avg Rafael Advanced Defense Systems Ltd. 13.6 avg CNH Industrial Canada, Ltd. 13.6 avg

atyr's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 46% higher than 54% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

aTyr Pharma, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	21	25.6%
2016	15	18.3%
2017	19	23.2%
2018	8	9.8%
2019	6	7.3%
2020	5	6.1%
2021	3	3.7%
2022	1	1.2%
2023	2	2.4%
2024	1	1.2%
2025partial year	1	1.2%

Which technologies does aTyr Pharma, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 79

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 78

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 76

C12Y - Enzymes 74

C07K - Peptides 74

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 58

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 10

Y02A - Technologies FOR Adaptation TO Climate Change 6

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 10 of 10 technology areas

Where it ranks

Overall rank by patents

#4,320

of 49,997 tracked assignees

Innovation Score

36.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

aTyr Pharma, Inc.'s patent record in context - here's where to go next.

aTyr Pharma, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 96.3% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #4,320 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare aTyr Pharma, Inc. against Ultralogic 6G, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.